Research peptides are not approved for human use in most countries including India. This page is for educational purposes only. Consult a physician before use.
What is GHRP-6?
GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide developed in the early 1980s — one of the first synthetic growth hormone releasing peptides ever created. It was developed as a research tool for studying GH secretion and the ghrelin receptor system, long before ghrelin itself was discovered in 1999.
GHRP-6 was the template from which the entire GHRP family was developed. All subsequent GHRPs — GHRP-2, ipamorelin, hexarelin — were engineered to improve upon specific limitations of GHRP-6 while retaining its core GH-releasing activity.
Mechanism and the Ghrelin Connection
GHRP-6 binds to GHS-R1a (ghrelin receptor/growth hormone secretagogue receptor 1a) on somatotroph cells in the anterior pituitary, triggering GH release. However, its binding is non-selective:
- Activates the GHS-R1a receptor for GH release
- Also significantly increases circulating ghrelin levels — the hunger hormone
- Activates pathways leading to ACTH and cortisol release
- Stimulates prolactin release
The ghrelin elevation is the root cause of GHRP-6's appetite stimulation. Ghrelin is the primary hunger-promoting hormone in humans. GHRP-6 injection produces ghrelin elevation within 30–45 minutes, causing intense hunger stimulation 2–3 times normal. For users trying to maintain caloric control while benefiting from GH stimulation, this is a significant problem.
The GHRP Family Evolution Timeline
Understanding GHRP-6's role requires context within the broader GHRP development history:
- GHRP-6 (1980s): First synthetic GHRP — strong GH pulse but non-selective, significant hunger/cortisol effects
- GHRP-2 (1990s): Modified structure → stronger GH pulse, reduced but not eliminated hunger and cortisol effects
- Ipamorelin (1998): Engineered for selectivity → removed hunger, cortisol, and prolactin effects entirely while maintaining clean GH pulse
- Hexarelin (1990s): Maximum potency but highest cortisol/prolactin — specialized applications only
Remaining Use Cases for GHRP-6
Despite being superseded by ipamorelin for most applications, GHRP-6 retains specific utility in certain contexts:
- Appetite stimulation applications: Clinical cachexia (cancer or chronic disease-related weight loss), post-surgical recovery, eating disorder support — the hunger effect is a feature, not a bug
- Maximum GH pulse cycling: Experienced users who want the strongest possible GH burst for short cycles and can manage the hunger effect
- Cost considerations: GHRP-6 is generally less expensive than ipamorelin — a consideration in cost-sensitive applications
- Research purposes: Understanding the full GHRP pharmacology for comparison and study purposes
GHRP-6 was the compound that proved GH secretion could be pharmacologically stimulated by non-GHRH peptides — a fundamental discovery. It opened the entire field of GH secretagogue research that eventually led to ipamorelin. Understanding GHRP-6 is essential for understanding why ipamorelin was developed and what it improved.
Complete GHRP Family Comparison
| Peptide | GH Potency | Hunger | Cortisol | Prolactin | Selectivity | Best Use |
|---|---|---|---|---|---|---|
| GHRP-6 | Strong | Strong (2–3×) | Significant | Significant | Low | Appetite stimulation, short cycles |
| GHRP-2 | Very strong | Moderate | Moderate | Moderate | Medium | Max GH short cycles |
| Ipamorelin | Moderate | Minimal | None | None | High | Daily longevity use |
| Hexarelin | Strongest | Moderate | High | High | Low | Cardiac, short cycles |
Dosing Protocol
- Dose: 100–300 mcg subcutaneously per injection on empty stomach
- Frequency: 1–3 injections per day (morning, pre-workout, before sleep)
- Empty stomach critical: Food/carbohydrates significantly blunt GH release — minimum 2 hours post-meal
- Hunger management: Have food available 30–45 minutes post-injection; hunger will be intense
- Combination: Often used with CJC-1295 no-DAC for synergistic effect
Frequently Asked Questions
GHRP-6 vs ipamorelin — which should I use?
For most longevity and body composition applications, ipamorelin is preferred. It was specifically engineered to remove the hunger stimulation and cortisol/prolactin elevation of GHRP-6, while retaining the GH pulse. GHRP-6's hunger effect makes it primarily useful in specific contexts where appetite stimulation is desired.
Why does GHRP-6 cause so much hunger?
GHRP-6 activates ghrelin receptors (GHS-R1a) but also significantly increases circulating ghrelin itself. Ghrelin is the primary hunger hormone. GHRP-6 injection triggers ghrelin elevation 30–45 minutes post-injection, causing hunger intensity 2–3 times normal.
What is the GHRP-6 dosage for growth hormone?
Standard GHRP-6 dosing is 100–300 mcg subcutaneously per injection on an empty stomach. Up to 3 injections per day can be used. Food — especially carbohydrates within 2 hours — will substantially reduce the GH pulse.
Is GHRP-6 or GHRP-2 better?
GHRP-2 is generally considered superior to GHRP-6 — it produces a stronger GH pulse with reduced (though not eliminated) hunger stimulation. However, both are largely superseded by ipamorelin for longevity purposes due to ipamorelin's cleaner selectivity profile.